eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
. blood-filled tick
.
family slam health trust after pensioner's 'undignified' death
.
.
the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men.
.
.
.
blood-filled tick
.
.,maxcontain(158,100),quality(90))
.
.